Preventable ADRs leading to hospitalization — results of a long-term prospective safety study with 6,427 ADR cases focusing on elderly patients

References

• Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother. 2008 Jul;42(7):1017–1025.
   PubMed Web of Science ®Google Scholar
• Bouvy JC, De Bruin ML, Koopmanschap MA. Epidemiology of adverse drug reactions in Europe: a review of recent observational studies. Drug Saf. 2015 May;38(5):437–453.
   PubMed Web of Science ®Google Scholar
• Benard-Laribiere A, Miremont-Salame G, Perault-Pochat MC, et al. EMIR Study Group on behalf of the French network of pharmacovigilance centres. Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study. Fundam Clin Pharmacol. 2015 Feb;29(1):106–111.
   PubMed Web of Science ®Google Scholar
• Chan SL, Ang X, Sani LL, et al. Prevalence and characteristics of adverse drug reactions at admission to hospital: a prospective observational study. Br J Clin Pharmacol. 2016 Dec;82(6):1636–1646.
   PubMed Web of Science ®Google Scholar
• Pedros C, Quintana B, Rebolledo M, et al. Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission. Eur J Clin Pharmacol. 2014 Mar;70(3):361–367.
   PubMed Web of Science ®Google Scholar
• Goettler M, Schneeweiss S, Hasford J. Adverse drug reaction monitoring–cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission. Pharmacoepidemiol Drug Saf. 1997 Oct;6(Suppl 3):S79–90.
   PubMedGoogle Scholar
• Hallas J, Gram LF, Grodum E, et al. Drug related admissions to medical wards: a population based survey. Br J Clin Pharmacol. 1992 Jan;33(1):61–68.
   PubMed Web of Science ®Google Scholar
• Leendertse AJ, Egberts AC, Stoker LJ, et al. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008 Sep 22;168(17):1890–1896.
   PubMed Web of Science ®Google Scholar
• Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004 Jul 3;329(7456):15–19.
   PubMed Web of Science ®Google Scholar
• Patel NS, Patel TK, Patel PB, et al. Hospitalizations due to preventable adverse reactions – a systematic review. Eur J Clin Pharmacol. 2017 Apr;73(4):385–398.
   PubMed Web of Science ®Google Scholar
• Alhawassi TM, Krass I, Bajorek BV, et al. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clin Interv Aging. 2014;9:2079–2086.
   PubMed Web of Science ®Google Scholar
• Davies EA, O’Mahony MS. Adverse drug reactions in special populations – the elderly. Br J Clin Pharmacol. 2015 Oct;80(4):796–807.
   PubMed Web of Science ®Google Scholar
• Budnitz DS, Lovegrove MC, Shehab N, et al. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011 Nov 24;365(21):2002–2012.
   PubMed Web of Science ®Google Scholar
• Hanlon JT, Schmader KE, Semla TP. Update of studies on drug-related problems in older adults. J Am Geriatr Soc. 2013 Aug;61(8):1365–1368.
   PubMed Web of Science ®Google Scholar
• Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med. 1997 Jul 28;157(14):1531–1536.
   PubMed Web of Science ®Google Scholar
• By the American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015 Nov;63(11):2227–2246.
   PubMed Web of Science ®Google Scholar
• Holt S, Schmiedl S, Thurmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010 Aug;107(31–32):543–551.
   PubMed Web of Science ®Google Scholar
• Endres HG, Kaufmann-Kolle P, Steeb V, et al. Association between potentially inappropriate medication (PIM) use and risk of hospitalization in older adults: an observational study based on routine data comparing PIM use with use of PIM alternatives. PloS One. 2016;11(2):e0146811.
   PubMed Web of Science ®Google Scholar
• van der Stelt CA, Vermeulen Windsant-Van Den Tweel AM, Egberts AC, et al. The association between potentially inappropriate prescribing and medication-related hospital admissions in older patients: a nested case control study. Drug Saf. 2016 Jan;39(1):79–87.
   PubMed Web of Science ®Google Scholar
• WHO. International drug monitoring. Geneva: The role of hospital; 1969.
   Google Scholar
• Schmiedl S, Rottenkolber M, Hasford J, et al. Self-medication with over-the-counter and prescribed drugs causing adverse-drug-reaction-related hospital admissions: results of a prospective, long-term multi-centre study. Drug Saf. 2014 Apr;37(4):225–235.
   PubMed Web of Science ®Google Scholar
• WHO. Anatomical therapeutic chemical (ATC) classification index. Geneva: WHO Collaborating Centre for Drug Statistics Methodology; 1992.
   Google Scholar
• Brown EG, Wood L, Wood S. The medical dictionary for regulatory activities (MedDRA). Drug Saf. 1999 Feb;20(2):109–117.
   PubMed Web of Science ®Google Scholar
• Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000 Oct 7;356(9237):1255–1259.
   PubMed Web of Science ®Google Scholar
• Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992 Sep;49(9):2229–2232.
   PubMedGoogle Scholar
• International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH). Maintenance of the ICH Guideline on Clinical Safety Data Management: Data Elements for Transmission of Individual Case Safety Reports E2B(R2). 2001 [cited 2010 09 24; Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E2B/Step4/E2B_R2__Guideline.pdf
   Google Scholar
• Begaud B, Evreux JC, Jouglard J, et al. [Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France]. Therapie. 1985 Mar-Apr;40(2):111–118.
   PubMed Web of Science ®Google Scholar
• Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992 Jun;27(6):538.
   PubMedGoogle Scholar
• Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003 Dec 8–22;163(22):2716–2724.
   PubMed Web of Science ®Google Scholar
• Laroche ML, Charmes JP, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol. 2007 Aug;63(8):725–731.
   PubMed Web of Science ®Google Scholar
• McLeod PJ, Huang AR, Tamblyn RM, et al. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. Cmaj. 1997 Feb 1;156(3):385–391.
   PubMed Web of Science ®Google Scholar
• O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015 Mar;44(2):213–218.
   PubMed Web of Science ®Google Scholar
• Schmiedl S, Rottenkolber M, Szymanski J, et al. Declining public health burden of digoxin toxicity: decreased use or safer prescribing? Clin Pharmacol Ther. 2009 Feb;85(2):143–144. author reply 44.
   PubMed Web of Science ®Google Scholar
• Schneeweiss S, Hasford J, Gottler M, et al. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol. 2002 Jul;58(4):285–291.
   PubMed Web of Science ®Google Scholar
• Clopper C, Pearson ES. The use of the confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934;26:404–413.
   Web of Science ®Google Scholar
• Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2007 Feb;63(2):136–147.
   PubMed Web of Science ®Google Scholar
• January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014 Dec 2;130(23):2071–2104.
   PubMed Web of Science ®Google Scholar
• Writing Committee M, Yancy CW, Jessup M, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 Oct 15;128(16):e240–327.
   PubMed Web of Science ®Google Scholar
• Belz GG, Breithaupt-Grogler K, Osowski U. Treatment of congestive heart failure–current status of use of digitoxin. Eur J Clin Invest. 2001;31(Suppl 2):10–17.
   PubMed Web of Science ®Google Scholar
• Peters U. Pharmacokinetic review of digitalis glycosides. Eur Heart J. 1982 Dec;3(Suppl):D:65–78.
   Google Scholar
• Segall L, Nistor I, Covic A. Heart failure in patients with chronic kidney disease: a systematic integrative review. Biomed Res Int. 2014;2014:937398.
   PubMed Web of Science ®Google Scholar
• Eschenhagen T. Herztherapeutika. In: Schwabe U, Paffrath D, eds. Arzneiverordnungs-Report 2009. Heidelberg, Germany; Springer–Medizin. 2009:581–596.
   Google Scholar
• Haynes K, Heitjan D, Kanetsky P, et al. Declining public health burden of digoxin toxicity from 1991 to 2004. Clin Pharmacol Ther. 2008 Jul;84(1):90–94.
   PubMed Web of Science ®Google Scholar
• Ardoino I, Rossio R, Di Blanca D, et al. Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people. Br J Clin Pharmacol. 2017 Nov;83(11):2528–2540.
   PubMed Web of Science ®Google Scholar
• Abraham NS, Singh S, Alexander GC, et al. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study. BMJ. 2015;350:h1857.
   PubMed Web of Science ®Google Scholar
• Larock AS, Mullier F, Sennesael AL, et al. Appropriateness of prescribing dabigatran etexilate and rivaroxaban in patients with nonvalvular atrial fibrillation: a prospective study. Ann Pharmacother. 2014 Oct;48(10):1258–1268.
   PubMed Web of Science ®Google Scholar
• Schmiedl S, Rottenkolber M, Szymanski J, et al. Bleeding complications and liver injuries during phenprocoumon treatment: a multicentre prospective observational study in internal medicine departments. Dtsch Arztebl Int. 2013 Apr;110(14):244–252.
   PubMed Web of Science ®Google Scholar
• Wilbur K, Hazi H, El-Bedawi A. Drug-related hospital visits and admissions associated with laboratory or physiologic abnormalities-a systematic-review. PloS One. 2013;8(6):e66803.
   PubMed Web of Science ®Google Scholar
• Hamilton H, Gallagher P, Ryan C, et al. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med. 2011 Jun 13;171(11):1013–1019.
   PubMed Web of Science ®Google Scholar
• Jano E, Aparasu RR. Healthcare outcomes associated with beers’ criteria: a systematic review. Ann Pharmacother. 2007 Mar;41(3):438–447.
   PubMed Web of Science ®Google Scholar
• O’Connor MN, O’Sullivan D, Gallagher PF, et al. Prevention of hospital-acquired adverse drug reactions in older people using screening tool of older persons’ prescriptions and screening tool to alert to right treatment criteria: a cluster randomized controlled trial. J Am Geriatr Soc. 2016 Aug;64(8):1558–1566.
   PubMed Web of Science ®Google Scholar
• Gillespie U, Alassaad A, Hammarlund-Udenaes M, et al. Effects of pharmacists’ interventions on appropriateness of prescribing and evaluation of the instruments’ (MAI, STOPP and STARTs’) ability to predict hospitalization–analyses from a randomized controlled trial. PloS One. 2013;8(5):e62401.
   PubMed Web of Science ®Google Scholar
• Verdoorn S, Kwint HF, Faber A, et al. Majority of drug-related problems identified during medication review are not associated with STOPP/START criteria. Eur J Clin Pharmacol. 2015 Oct;71(10):1255–1262.
   PubMed Web of Science ®Google Scholar
• Hakkarainen KM, Andersson Sundell K, Petzold M, et al. Methods for assessing the preventability of adverse drug events: a systematic review. Drug Saf. 2012 Feb 1;35(2):105–126.
   PubMed Web of Science ®Google Scholar